Advertisement

Loading...

IM Cannabis Corp.

IMCC.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.10
$-3.40(-40.00%)
Canadian Market opens in 16h 37m

IM Cannabis Corp. Fundamental Analysis

IM Cannabis Corp. (IMCC.CN) shows moderate financial fundamentals with a PE ratio of -8.05, profit margin of -3.94%, and ROE of -41.25%. The company generates $0.1B in annual revenue with strong year-over-year growth of 10.71%.

Key Strengths

PEG Ratio-0.13

Areas of Concern

ROE-41.25%
Operating Margin-36.11%
Cash Position4.77%
Current Ratio0.72
We analyze IMCC.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -28.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-28.8/100

We analyze IMCC.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

IMCC.CN struggles to generate sufficient returns from assets.

ROA > 10%
-5.03%

Valuation Score

Excellent

IMCC.CN trades at attractive valuation levels.

PE < 25
-8.05
PEG Ratio < 2
-0.13

Growth Score

Moderate

IMCC.CN shows steady but slowing expansion.

Revenue Growth > 5%
10.71%
EPS Growth > 10%
-1.35%

Financial Health Score

Weak

IMCC.CN carries high financial risk with limited liquidity.

Debt/Equity < 1
4.44
Current Ratio > 1
0.72

Profitability Score

Weak

IMCC.CN struggles to sustain strong margins.

ROE > 15%
-4125.13%
Net Margin ≥ 15%
-3.94%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is IMCC.CN Expensive or Cheap?

P/E Ratio

IMCC.CN trades at -8.05 times earnings. This suggests potential undervaluation.

-8.05

PEG Ratio

When adjusting for growth, IMCC.CN's PEG of -0.13 indicates potential undervaluation.

-0.13

Price to Book

The market values IM Cannabis Corp. at 4.72 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.72

EV/EBITDA

Enterprise value stands at -2.57 times EBITDA. This is generally considered low.

-2.57

How Well Does IMCC.CN Make Money?

Net Profit Margin

For every $100 in sales, IM Cannabis Corp. keeps $-3.94 as profit after all expenses.

-3.94%

Operating Margin

Core operations generate -36.11 in profit for every $100 in revenue, before interest and taxes.

-36.11%

ROE

Management delivers $-41.25 in profit for every $100 of shareholder equity.

-41.25%

ROA

IM Cannabis Corp. generates $-5.03 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.03%

Following the Money - Real Cash Generation

Operating Cash Flow

IM Cannabis Corp. generates limited operating cash flow of $2.63M, signaling weaker underlying cash strength.

$2.63M

Free Cash Flow

IM Cannabis Corp. produces free cash flow of $2.52M, offering steady but limited capital for shareholder returns and expansion.

$2.52M

FCF Per Share

Each share generates $0.75 in free cash annually.

$0.75

FCF Yield

IMCC.CN converts 14.19% of its market value into free cash.

14.19%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.05

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.13

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.72

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.33

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

4.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.72

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.41

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

-3.20

vs 25 benchmark

How IMCC.CN Stacks Against Its Sector Peers

MetricIMCC.CN ValueSector AveragePerformance
P/E Ratio-8.0527.91 Better (Cheaper)
ROE-41.25%687.00% Weak
Net Margin-3.94%-45285.00% (disorted) Weak
Debt/Equity4.440.33 Weak (High Leverage)
Current Ratio0.722795.76 Weak Liquidity
ROA-5.03%-13557.00% (disorted) Weak

IMCC.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews IM Cannabis Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

710.66%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-97.62%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

75.39%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ